Mark Porter1, Roomasa Channa2, Jessica Wagner3, Laura Prichett3, Tin Yan Alvin Liu2, Risa M Wolf1. 1. Pediatric Endocrine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 2. Ophthalmology, Wilmer Eye Institute at the Johns Hopkins University, Baltimore, Maryland, USA. 3. Epidemiology and Data Management (BEAD) Core, Johns Hopkins School of Medicine Biostatistics, Baltimore, Maryland, USA.
Abstract
BACKGROUND: Diabetic retinopathy (DR) is a serious complication that can progress to sight-threatening disease. The prevalence of DR in youth with diabetes has been reported to be 3.8% to 20%. OBJECTIVE: We aimed to evaluate the prevalence of DR among youth with diabetes at a large ophthalmologic referral center. Secondary goals were to determine the risk factors for DR and severity of disease. METHODS: Retrospective chart review of 343 patients with diabetes, <21 years of age, seen at a tertiary referral eye care center from 2013 to 2018. RESULTS: The study included 343 patients, of which 293 had type 1 diabetes (T1D) and 50 had type 2 diabetes (T2D). Thirteen of 343 patients had DR, with an overall incidence of 3.8% (3.4% in T1D and 6% T2D). DR severity included nine with mild non-proliferative, three moderate non-proliferative, and one with proliferative DR. Patients with hemoglobin A1c (HbA1c) > 8% had a higher risk of DR (P = .049). In this cohort, none of the patients with an HbA1c <8% had DR. In the multivariate analysis, a higher systolic blood pressure was marginally associated with risk for DR (P = .07). CONCLUSIONS: We found lower prevalence of DR in youth with diabetes than previously reported. The incidence of DR was higher among patients with T2D and occurred with a shorter duration of disease, as compared with T1D. While the incidence of DR in youth with T1D is low, with the increasing incidence of T2D in adolescents and early risk for DR, early screening must be emphasized.
BACKGROUND:Diabetic retinopathy (DR) is a serious complication that can progress to sight-threatening disease. The prevalence of DR in youth with diabetes has been reported to be 3.8% to 20%. OBJECTIVE: We aimed to evaluate the prevalence of DR among youth with diabetes at a large ophthalmologic referral center. Secondary goals were to determine the risk factors for DR and severity of disease. METHODS: Retrospective chart review of 343 patients with diabetes, <21 years of age, seen at a tertiary referral eye care center from 2013 to 2018. RESULTS: The study included 343 patients, of which 293 had type 1 diabetes (T1D) and 50 had type 2 diabetes (T2D). Thirteen of 343 patients had DR, with an overall incidence of 3.8% (3.4% in T1D and 6% T2D). DR severity included nine with mild non-proliferative, three moderate non-proliferative, and one with proliferative DR. Patients with hemoglobin A1c (HbA1c) > 8% had a higher risk of DR (P = .049). In this cohort, none of the patients with an HbA1c <8% had DR. In the multivariate analysis, a higher systolic blood pressure was marginally associated with risk for DR (P = .07). CONCLUSIONS: We found lower prevalence of DR in youth with diabetes than previously reported. The incidence of DR was higher among patients with T2D and occurred with a shorter duration of disease, as compared with T1D. While the incidence of DR in youth with T1D is low, with the increasing incidence of T2D in adolescents and early risk for DR, early screening must be emphasized.
Authors: David M Nathan; Ionut Bebu; Dean Hainsworth; Ronald Klein; William Tamborlane; Gayle Lorenzi; Rose Gubitosi-Klug; John M Lachin Journal: N Engl J Med Date: 2017-04-20 Impact factor: 91.245
Authors: Steven M Willi; Kellee M Miller; Linda A DiMeglio; Georgeanna J Klingensmith; Jill H Simmons; William V Tamborlane; Kristen J Nadeau; Julie M Kittelsrud; Peter Huckfeldt; Roy W Beck; Terri H Lipman Journal: Pediatrics Date: 2015-03 Impact factor: 7.124
Authors: Rose A Gubitosi-Klug; Ionut Bebu; Neil H White; John Malone; Ryan Miller; Gayle M Lorenzi; Dean P Hainsworth; Victoria R Trapani; John M Lachin; William V Tamborlane Journal: Pediatr Diabetes Date: 2019-07-09 Impact factor: 4.866
Authors: A Kernell; I Dedorsson; B Johansson; C P Wickström; J Ludvigsson; T Tuvemo; J Neiderud; K Sjöström; K Malmgren; P Kanulf; L Mellvig; M Gjötterberg; J Sule; L A Persson; L I Larsson; J Aman; G Dahlquist Journal: Diabetologia Date: 1997-03 Impact factor: 10.122
Authors: Xinzhi Zhang; Jinan B Saaddine; Chiu-Fang Chou; Mary Frances Cotch; Yiling J Cheng; Linda S Geiss; Edward W Gregg; Ann L Albright; Barbara E K Klein; Ronald Klein Journal: JAMA Date: 2010-08-11 Impact factor: 56.272
Authors: Neil H White; Wanjie Sun; Patricia A Cleary; William V Tamborlane; Ronald P Danis; Dean P Hainsworth; Matthew D Davis Journal: Diabetes Date: 2010-02-11 Impact factor: 9.461
Authors: P Massin; A Erginay; I Mercat-Caudal; S Vol; N Robert; G Reach; M Cahane; J Tichet Journal: Diabetes Metab Date: 2007-07-10 Impact factor: 6.041
Authors: Vera A Essuman; Naa N Tagoe; Akye Essuman; Benjamin Abaidoo; Josephine Akpalu; Harold A Sackey; Charles F Hayfron-Benjamin; George Asare; Albert G B Amoah; Thomas A Ndanu; Imelda D B Ofori-Adjei; Nana A Barnes; Benedicta L Appiah-Thompson; Winfried M Amoaku Journal: Int J Environ Res Public Health Date: 2022-04-27 Impact factor: 4.614